The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer


Kemik O., Kemik A., Sumer A., Almalı N., Gurluler E. , Gures N., ...More

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, no.21, pp.2923-2928, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 21
  • Publication Date: 2013
  • Title of Journal : EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Page Numbers: pp.2923-2928
  • Keywords: Tumor-associated trypsin inhibitor, Clinical-pathological features, Gastric cancer, COLON-CANCER, EXPRESSION, TATI, FIBROBLASTS, ANTIGEN, URINE

Abstract

BACKGROUND: Tumor-associated trypsin inhibitor (TATI) is expressed with trypsinogen in tumors. We studied the clinical-pathologic association and significance of preoperative serum levels of TATI in gastric cancer patients.